Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity
Clinical trial NCT01296815 · COMPLETED
Trial details
- NCT number
- NCT01296815
- Sponsor
- Centro de Investigación en. Enfermedades Infecciosas, Mexico
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2012-12-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.